glp 1 drug differences GLP-1 Agonists Explained: Definition, How They Work, Side Effects GLP-1 drugs linked to reduced
Description
Endocrinology (2017) 158(12):421832
All content is strictly informational and should not be considered medical advice
Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjth TV, et al
Despite these therapeutic advances, the metabolic consequences of sustained pharmacologically induced hypophagia remain incompletely characterized
Among adults ages 50-64, 15% say they have taken GLP-1 drugs to treat a chronic condition and 5% say theyve taken them for weight loss only
In obese patients, acipimox can inhibit adipose tissue lipolysis by activating protein upregulated in macrophage by INF- (PUMA-G) (also known as the hydroxycarboxylic acid receptor 2 [HCA2] and GPR109a) receptors
